Zurich Cantonal Bank
KRRO icon

Zurich Cantonal Bank’s Korro Bio KRRO Stock Holding History

Zurich Cantonal Bank’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-31
Closed -$8K – 2785
2021
Q4 		$8K Sell
31
-4
-11% -$1.22K ﹤0.01% 2893
2021
Q3 		$12K Hold
35
– – ﹤0.01% 2806
2021
Q2 		$17K Buy
35
+2
+6% +$977 ﹤0.01% 2584
2021
Q1 		$16K Buy
+33
New +$64.1K ﹤0.01% 2532

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Zurich Cantonal Bank's KRRO Position: Q1 2022 in Review

Zurich Cantonal Bank sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 31 shares — an estimated $8K sold.

Zurich Cantonal Bank first reported a position in KRRO in Q1 2021 and held it in 4 quarters. The position peaked at $17K in Q2 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Zurich Cantonal Bank reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 31 Korro Bio shares in Q1 2022, an estimated $8K.
  • Zurich Cantonal Bank first reported a position in Korro Bio in Q1 2021 and held it in 4 quarters.
  • Zurich Cantonal Bank's Korro Bio position peaked at $17K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.